William Blair Downgrades Adamas Pharmaceuticals to Market Perform
William Blair analyst Tim Lugo downgrades Adamas Pharmaceuticals (NASDAQ:ADMS) from Outperform to Market Perform.
Supernus Bolsters Parkinson’s Portfolio With $450M Adamas Buyout: Highlights
Supernus Pharmaceuticals Inc (NASDAQ:SUPN) has agreed to acquire Adamas Pharmaceuticals Inc (NASDAQ:ADMS) for $9.10 per share, or $450 million. The deal consideration…
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers
Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market session. The market value of their outstanding shares is at $1.6 billion.
Supernus Pharmaceuticals To Acquire Adamas Pharmaceuticals For $8.10/Share Or An Aggregate Of ~$400M
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) and Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS), today announced a definitive agreement for Supernus to acquire Adamas through a tender offer for $8.10 per share in cash (or an
Looking Into Adamas Pharmaceuticals’s Return On Capital Employed
According to data from Benzinga Pro, during Q2, Adamas Pharmaceuticals's (NASDAQ:ADMS) reported sales totaled $21.97 million. Despite a 3.88% increase in earnings, the company posted a loss of $9.15 million.
Adamas Pharmaceuticals Q2 EPS $(0.27) Beats $(0.29) Estimate, Sales $22.00M Beat $21.95M Estimate
Adamas Pharmaceuticals (NASDAQ:ADMS) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.29) by 6.9 percent. This is a 27.03 percent increase over losses of $(0.37) per share
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
Earnings Scheduled For May 10, 2021
Companies Reporting Before The Bell
• Revlon (NYSE:REV) is likely to report earnings for its first quarter.
• Bluegreen Vacations (NYSE:BVH) is expected to report earnings for its first quarter.